Home / Recalls / Redline Pharmacy Solutions / D-1008-2020

D-1008-2020 Class II Terminated

Recalled by Redline Pharmacy Solutions — Hastings, NE

FDA drug recall D-1008-2020 was initiated by Redline Pharmacy Solutions on February 24, 2020 and is designated Class II. Reason for recall: Lack Of Processing Controls The recall status is terminated (terminated March 31, 2022). Affected quantity: 16 doses.

Recall Details

Product Type
Drugs
Report Date
March 18, 2020
Initiation Date
February 24, 2020
Termination Date
March 31, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16 doses

Product Description

Daptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901

Reason for Recall

Lack Of Processing Controls

Distribution Pattern

Sold to patients in Nebraska

Code Information

Lots 02242020@3, 02242020@9

Other recalls by Redline Pharmacy Solutions

  • D-1009-2020 Class II — Ertapenem in 100ML 0.9% NACL 1GM Injectable, Redline Specialty Pharmacy, 2415 O (February 24, 2020)
  • D-1007-2020 Class II — Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Ph (February 24, 2020)
  • D-1011-2020 Class II — Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Speci (February 24, 2020)
  • D-1006-2020 Class II — Acetylcysteine Ophthalmic 10% Solution, 5 mL per dropper bottle (10ML). Redline (February 24, 2020)
  • D-1010-2020 Class II — Vancomycin 900MG in 100ML 0.9% NACL Injectable, Redline Specialty Pharmacy, 241 (February 24, 2020)

FDA data resources